drugset / Trial / NCT06116786
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine a safe and tolerable dose(s) of JNJ-86974680 for further research in combination with cetrelimab and radiation therapy.
Timeline
- Start
- 2023-11-27
- Primary completion
- 2027-04-14
- Completion
- 2027-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-86974680 | Unknown | — | — |
| Background | Cetrelimab | Monoclonal antibody | — | — |